Travelers (TRV) Q2 results

On 7/23, Travelers reported a Q2 EPS loss of $-.20, in-line with expectations.  Results were hit by catastrophe losses for storms and civil unrest.  Losses related to the pandemic continue to be small (-$50m) partially offset by lower auto incidents.  Positives for the quarter were improving underlying margin improvement and continued strong pricing gains.

 

Travelers is a high quality, disciplined underwriter of insurance that is focused on returning capital to shareholders through dividends and share buybacks. 

 

Current Price: $118.61                          Price Target: $120

Position Size:   1.56%                               TTM Performance: -18.3%

 

Thesis Intact. Key takeaways from the quarter:

 

  1. Despite cat losses, core business results were solid

·         Combined ratio ex-cats of  91.4% ahead of expected 96.3%

·         Net premiums declined -1%, again ahead of expectations and not bad given environment

·         Strong pricing with renewal premiums up 2.5% to 7.8%.  The industry has faced several headwinds – higher cat losses, negative tort trends and falling yields.  As a result industry wide pricing has been strongest in 10 years:

               

 

  1. Net Investment Income fell $24m due to lower rates.  Non fixed-income investment results were down $-180m as these are reported with a lag of one quarter.
  2. Strong financial position
    • Debt to capital ratio of 23.2%
    • Most of debt is long term – just issued a 30yr bond yielding 2.5%
    • 97.9% of fixed income portfolio is investment grade with average rating of AA
    • Strong rankings from rating agency relative to peers

 

  1. TRV yields 2.87% – for Q2 2020 TRV did not buyback any share which is the first quarter in 10+ years.
    • First quarter in 10+ years that they did not buyback shares – Many financial companies have delayed share buybacks given optics of current environment
    • Over past 10 year shares outstanding have fallen 53%!
    • Management has a long history of employing capital wisely! Instead of investing in mature business with spotty pricing, they are returning excess capital to shareholders

 

5.       Current valuation of 12.3 P/E is close to historical mean.  Price target represents 12x 2021’s estimated earnings.

 

The Thesis on TRV:

  • We expect TRV will be able to grow book value per share in the mid-single digits over the near-medium term, and generate ROE in the 10-14% range
  • Industry leader with disciplined underwriting and investment portfolio track record  
  • Consistent returns in the low to mid double digits
  • Responsible capital allocation and proven desire to act in the best interests of shareholders

 

 

Please let me know if you have any questions.

Thanks,

John

 

$TRV.US

[category earnings ]

[tag TRV]

 

 

John R. Ingram CFA

Chief Investment Officer

Partner

 

Direct: 617.226.0021

Fax: 617.523.8118

 

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com